12|1|Public
50|$|Oxabolone is a {{synthetic}} anabolic-androgenic steroid (AAS). It can be formulated as the <b>cipionate</b> ester prodrug oxabolone <b>cipionate.</b>|$|E
50|$|Nandrolone cypionate (brand names Anabo, Depo-Nortestonate, Dynabol, Nortestrionate, Pluropon, Sterocrinolo), or {{nandrolone}} <b>cipionate,</b> {{also known}} as 19-nortestosterone 17β-cyclopentanepropionate, is a synthetic androgen and anabolic steroid and a nandrolone ester.|$|E
50|$|Testosterone cypionate (brand names Depo-Testosterone, many others), or {{testosterone}} <b>cipionate,</b> {{also known}} as testosterone cyclopentylpropionate or testosterone cyclopentanepropionate, is an androgen and anabolic steroid and a testosterone ester. Along with testosterone enanthate, testosterone propionate, and testosterone undecanoate, {{it is one of}} the most widely used testosterone esters.|$|E
50|$|Cypionic acid is a {{carboxylic}} acid with the molecular formula C8H14O2. Its salts and esters {{are known as}} cypionates or <b>cipionates.</b>|$|R
50|$|Oxabolone <b>cipionate</b> (INN, JAN) (brand names Steranabol Depo, Steranabol Ritardo; former {{developmental}} {{code name}} FI-5852), or oxabolone cypionate, {{also known as}} 4-hydroxy-19-nortestosterone 17β-cypionate or estr-4-en-4,17β-diol-3-one 17β-cypionate, is synthetic, injected anabolic-androgenic steroid (AAS) and derivative of 19-nortestosterone (nandrolone) that has been marketed in Europe. It is the C17β cypionate ester and a prodrug of oxabolone (4-hydroxy-19-nortestosterone).|$|E
50|$|Estradiol cypionate (EC, E2C) (INN, USAN) (brand name Depo-Estradiol, many others), or {{estradiol}} <b>cipionate,</b> {{also known}} as estradiol 17β-cyclopentylpropionate or estradiol 17β-cyclopentanepropionate, is a synthetic, steroidal estrogen and an estrogen ester - specifically, the 17β-cypionate (cyclopentylpropionate) ester of estradiol - which is marketed in the United States, Canada, Europe, and {{throughout much of the}} rest of the world. It acts as a prodrug of estradiol, and hence, is considered to be a natural, bioidentical form of estrogen. Along with estradiol valerate, estradiol cypionate is one of the most widely used esters of estradiol.|$|E
40|$|The {{metabolism}} of oxabolone <b>cipionate,</b> 17 -(3 -cyclopentyl- 1 -oxopropoxy) - 4 -hydroxyestr- 4 -en- 3 -one, {{a synthetic}} anabolic steroid, {{was investigated in}} man, the cumulative urinary excretion and the metabolism of the compounds being studied by GC-MS in both electron impact and chemical ionization modes. After administration by injection to volunteers, five different metabolities were detected in urine. The metabolites and the parent compound were detected in urine {{up to a week}} after administration...|$|E
40|$|The aim of {{this work}} was to prepare the mares for embryo transfer. In group 1 (G 1,treated, n= 15), {{recipient}} mares in anoestrus or in a transition period were treated with 5. 0, 3. 0 and 2. 0 mg of estradiol <b>cipionate</b> at the days 0, 1 and 2 respectively, beginning at the day of ovulation (DO). From the fourth day on, the mares this group received long-acting progesterone weekly, up to the 120 day of gestation. At D 8, the embryo was collected from the donor and transferred to the recipient. At D 12, the ultrasonographyc diagnosis of pregnancy was carried out. The control group (G 2, not treated, n= 20) was formed by cycling recipient mares, displaying ovulation at each 2 to 3 days after the donors mare ovulation. The pregnancy rate was higher (p< 0. 05) in the mares from G 2 (85. 0 %) than from G 1 (53. 3 %). Thus, it could be concluded that the treated mares although showed lesser pregnancy rate than the cycling mare, were satisfactory alternative to be used mainly {{when there is no}} available cycling recipient...|$|E
40|$|Androgens exert {{their effects}} on {{various parts of the}} body, {{including}} muscles, bones, hair follicles in the skin, liver and kidney, reproductive, hematic, immune and nervous systems. The effects are modulated by specific cellular "steroid-converting" enzymes, located inside target tissues. All the anabolic steroids currently used are derivates of testosterone or changes of its structure. The most important esterified forms of testosterone include the propionate, <b>cipionate,</b> enhantate and undecanoate ones. The mechanism of action of AAS has not been fully elucidated and it is currently subject of many studies. Several mechanism of action have been proposed to identify the path activated by AAS. Some, like oximetholone, does not bind the androgen receptors: it is assumed that these steroids act after a biological transformation into more active compounds. The 5 alpha-reductase, for example, plays a central role in their mechanism of action; on the other hand, aromatase is responsible for the conversion of AAS in female sex hormones such as estradiol and estrone, which bind to the estrogen receptor, forming estrogen-receptor complex. Steroid hormone receptors (SHRs) are members of the superfamily of nuclear and steroid receptors. In particolar, the functions of the androgen receptors (hAR) involving transciption factors are generally regulated by specific steroid ligands, that is androgens and selective androgen receptor modulators (SARMs) ...|$|E
40|$|O objetivo neste trabalho foi verificar o efeito do estrógeno exógeno em fase precoce do ciclo estral na indução do estro e na dinâmica ovariana de vacas leiteiras. Considerando que a PGF 2 &# 945; não regride o corpo lúteo com menos de cinco dias após o estro, uma das alternativas para a redução do intervalo estral no início do ciclo seria o uso do estrógeno. Foram utilizadas 16 vacas mestiças Holandês-Zebu ciclando regularmente, sem qualquer alteração clínica ou reprodutiva. As vacas foram incluídas ao acaso nos respectivos tratamentos. Oito delas receberam 2, 5 mL de cipionato de {{estradiol}} no primeiro dia do ciclo estral e oito não receberam (controle). A manifestação de estro foi monitorada visualmente. Os exames ultrassonográficos foram realizados diariamente pela manhã, iniciando no dia do estro. As coletas de sangue para as dosagens de progesterona tiveram início no dia do estro. Os animais que receberam estrógeno no primeiro dia após o estro natural manifestaram os sinais característicos de estro (psíquicos, útero túrgido e muco abundante) um dia após a aplicação. Essa redução do intervalo de estro para apenas dois dias pode favorecer a eliminação de bactérias do útero (quando presentes), aumentando a eficiência reprodutiva. Excetuando o dia da emergência da primeira onda folicular, todas as outras variáveis estudadas (número e comprimento de ondas, características dos folículos dominantes e subordinados, assim como os parâmetros relacionados ao corpo lúteo) não foram afetadas pela aplicação de estrógeno um dia após o estro. A aplicação de cipionato de estradiol em vacas mestiças um dia após o estro natural promove o aparecimento de sinais de estro dois dias após o estro natural mas não afeta as características do ciclo estral subsequente. The {{objective of}} this work was to check the effect of exogenous estrogen, in early phase of estrus cycle on the induction of estrus and on ovarian dynamics of dairy cows. By considering that PGF 2 &# 945; does not regress the corpus luteum {{in less than five}} days after the estrus, an alternative for the reduction of the estrus interval {{in the beginning of the}} cycle would be the use of estrogen. It was used 16 Holstein-zebu crossbred cows cycling regularly, without any clinical or reproductive alterations. Cows were randomly included in their respective treatments. Eight cows received 2. 5 mL of estradiol <b>cipionate</b> on the first day of the estrous cycle and eight cows did not receive anything (control). The expression of estrus was monitored visually. The ultrasound scans were conducted daily in the morning, starting on the estrus day. The blood collections for the measurements of the levels of progesterone began on the estrus day. All the animals that received estrogen on the first day after natural estrus showed the estrus characteristical signals (psychics, turgid uterus and abundant mucus) one day after application. This reduction of estrus interval to only two days can promote the elimination of uterus bacteria (if present), consequently enhancing the reproductive efficiency. Except for the the day of the first follicular wave emergence, all the other studied variables (wave number and length, characteristics of dominant and subordinate follicles and the parameters related to the corpus luteum) were not affected by the application of estrogen on the day after the estrus. The application of estradiol <b>cipionate</b> in crossbred cows one day after the natural estrus promote the emergence of estrus sign two days after the natural estrus, without affecting the characteristics of the next estrous cycle...|$|E
40|$|Dezesseis cabras nulíparas da raça Saanen foram distribuídas em dois grupos de tratamentos (T 1 e T 2) para sincronização da ovulação. Inicialmente, ambos os tratamento consistiram na aplicação concomitante do dispositivo de liberação controlada de drogas (CIDR-G®), de 5 mg de {{dinoprost}} e de 1 mg de cipionato de estradiol (CE) (dia 0). No quarto dia aplicaram-se 250 UI de eCG e no quinto dia retirou-se o CIDR-G®. As cabras do T 1 (n= 8) receberam 1 mg de CE 24 horas depois da retirada do CIDR-G® e as do T 2 (n= 8) receberam 250 UI de hCG 30 horas após. Sete cabras do T 1 e oito do T 2 entraram em estro depois da retirada do CIDR-G®. Cabras que receberam hCG permaneceram em estro por 42, 0 ± 6, 9 horas e as que receberam CE por 45, 0 ± 5, 5 horas (P> 0, 05). As características ovulatórias não foram influenciadas pelos tratamentos. O intervalo da retirada do CIDR-G® à ovulação para ambos os protocolos de sincronização da ovulação não diferiu (P> 0, 05) entre tratamentos. As ovulações promovidas pelo CE ocorreram em menor intervalo de tempo. Saanen nuliparous female goats {{were distributed}} in two experimental groups of eight animals each to synchronize the ovulation. On day zero, all animals {{were treated with}} controlled internal drug release (CIDR-G®), dinoprost (5 mg) and estradiol <b>cipionate</b> (EC; 1 mg). On day 4, all animals were treated with eCG (250 IU), and on day 5 the CIDR-G® was removed. Group 1 (T 1) received 1 mg of EC and Group 2 (T 2) received 250 IU of hCG, 24 and 30 hours after CIDR-G® removal, respectively. Onset of estrus was observed in 7 and 8 goats of T 1 and T 2 groups, respectively. hCG treated goats remained in estrus for 42 ± 6. 9 hours, whereas EC-treated goats remained in estrus for 45 ± 5. 5 hours (P> 0. 05). None of the studied ovulatory characteristics were affected by treatments. The intervals between CIDR-G® removal and ovulation in T 1 and T 2 groups were similar. Both hCG and EC were equally efficient on inducing ovulation synchronically...|$|E
40|$|O presente trabalho foi realizado em duas etapas experimentais. O objetivo do Experimento 1 foi avaliar o perfil de produção de anticorpos anti-eCG em novilhas Bos taurus e Bos indicus tratadas uma, duas ou três vezes, com 400 e com 2000 UI de eCG. O experimento foi realizado em duas réplicas com o mesmo desenho experimental, porém com padrões raciais distintos. Os animais foram divididos em 6 grupos: os grupos eCG 2000 UI_ 1 x (n = 5), eCG 2000 UI_ 2 x (n = 5) e eCG 2000 UI_ 3 x (n = 5) receberam, respectivamente, um, dois e três tratamentos com 2000 UI de eCG, enquanto os grupos eCG 400 UI_ 1 x (n = 5), eCG 400 UI_ 2 x (n = 5) e eCG 400 UI_ 3 x (n = 5) receberam os mesmos tratamentos porém com 400 UI de eCG. Foram {{realizadas}} coletas de sangue semanais por um período de 63 dias, em seguida o intervalo entre as coletas foi de 30 e 60 dias totalizando um período de 300 dias. A dosagem dos anticorpos anti-eCG foi realizada por teste ELISA. O número de tratamentos não influenciou a produção de anticorpos anti-eCG; a produção de anticorpos foi maior em fêmeas Bos taurus que em Bos indicus, e a aplicação de 2000 UI de eCG resultou em maiores concentrações de anticorpos que a aplicação de 400 UI nos primeiros 21 dias após o tratamento e na resposta tardia. O objetivo do Experimento 2 foi avaliar a memória imunológica celular e humoral de fêmeas Bos taurus previamente tratadas com 400 e 2000 UI de eCG, e verificar a influência dessa possível memória imunológica na atividade biológica da molécula de eCG. Além dos animais utilizados no experimento anterior, no Experimento 2 foram incluídos outros nove animais sem tratamento prévio com eCG: eCG 2000 UI_Controle (n = 5) e eCG 400 UI_Controle (n = 4). No D 0 os animais receberam 2 mg de benzoato de estradiol e um dispositivo intravaginal de progesterona (DIB). Quatro dias mais tarde, as fêmeas dos grupos eCG 2000 UI_ 1 x, eCG 2000 UI_ 2 x, eCG 2000 UI_ 3 x e eCG 2000 UI_Controle receberam 2000 UI de eCG, enquanto as fêmeas dos grupos eCG 400 UI_ 1 x, eCG 400 UI_ 2 x, eCG 400 UI_ 3 x e eCG 400 UI_Controle receberam 400 UI de eCG. No momento da retirada do DIB (D 8) os animais receberam PGF 2 e 1 mg de cipionato de estradiol. Foram realizadas coletas de sangue semanais por 32 dias para dosagem de anticorpos, e duas coletas para avaliação da atividade celular proliferativa no D 0 e D 32. No momento da retirada do DIB as novilhas foram submetidas a exame ultrassonográfico para avaliação da resposta superestimulatória (no. de folículos > 6 mm) e para mensuração do diâmetro do maior folículo nas fêmeas tratadas com 2000 e 400 UI de eCG, respectivamente. O tratamento prévio não gerou memória imunológica humoral, independente da dose e do número de tratamentos realizados. No entanto, foi observada memória imunológica celular, sendo que esta memória foi maior nos animais submetidos a maior número de tratamentos prévios. Foi observada tendência de efeito de réplica na resposta superestimulatória, e correlação negativa entre a concentração de anticorpos e o número de folículos > 6 mm. O tratamento com 400 UI de eCG não mostrou os mesmos efeitos no diâmetro folicular. The {{present study}} {{was carried out in}} two experimental steps. Experiment 1 was designed to evaluate the anti-eCG antibodies production in Bos taurus and Bos indicus heifers, in response to 400 and 2000 UI of eCG, employed once, twice or three times. This experiment was performed in two identical experimental designs, however, using distinct genetic groups. Animals where randomly divided in six groups: eCG 2000 UI_ 1 x (n = 5), eCG 2000 UI_ 2 x (n = 5) and eCG 2000 UI_ 3 x (n = 5) were respectively treated with one, two and three injections of 2000 UI of eCG. Groups eCG 400 UI_ 1 x (n = 5), eCG 400 UI_ 2 x (n = 5) and eCG 400 UI_ 3 x (n = 5) were submitted to the same treatment protocol aforementioned; however, eCG dose was 400 UI. Animals where then submitted to weekly blood sampling during a 63 days period, and then samples were collected within intervals ranging from 30 - 60 days, totalizing a period of 300 days. Anti-eCG dosage assay was performed by ELISA. Antibody production was not affected by the number of doses; however, was higher in Bos taurus females. Moreover, higher antibodies levels in the first 21 days after treatment and in the late response were observed when 2000 UI of eCG was applied. The Experiment 2 was focused on the evaluation of cellular and humoral immunological memory of Bos Taurus females previously treated with 400 and 2000 UI of eCG, as well as to figure out influence of the possible immunological response on biological activity of eCG molecule. Besides the animals that were used in the first experiment, nine additional heifers were included in the second trial, which were eCG 2000 UI_Control (n = 5) and eCG 400 UI_Control (n = 4). The treatment protocol was: on Day 0 (D 0) all heifers received 2 mg of estradiol benzoate and one intravaginal progesterone device (DIB). Four days later, groups eCG 2000 UI_ 1 x, eCG 2000 UI_ 2 x, eCG 2000 UI_ 3 x and eCG 2000 UI_Control received an injection of 2000 UI eCG, while groups eCG 400 UI_ 1 x, eCG 400 UI_ 2 x, eCG 400 UI_ 3 x and eCG 400 UI_Control received 400 UI. By the time of DIB withdrawal (D 8), animals were treated with PGF 2 plus 1 mg of estradiol <b>cipionate</b> treatment. Afterwards, weekly blood samples were collected during 32 days for antibodies assay. Two additional blood samples were performed on day D 0 and D 32 to evaluate the cellular proliferative activity in response to eCG. In order to evaluate the ovarian stimulatory response (number of follicles > 6 mm) in heifers treated with 2000 UI of eCG as well as the size of the largest follicle in those heifers treated with 400 UI, ultrasound examination was carried by the time of DIB withdrawal. Humoral immunological memory response was not observed in animals previously treated with 400 or 2000 UI of eCG, regardless the number of treatments. Otherwise, cellular immunological memory response was observed and was higher in animals subjected to an increased number of treatments. A tendency of replicate effect in follicle numbers (> 6 mm) was observed, as well as a high negative correlation between antibodies concentration and the number of follicles > 6 mm. Same results were not observed when 400 UI of eCG treatment was performed...|$|E
40|$|A {{literatura}} científica apresenta diversas maneiras de treinamento físico e constantemente reitera que a utilização de modelos animais em estudos sobre o efeito do treinamento visto a possibilidade de avaliar variáveis como volume e intensidade, já que as respostas encontradas nos animais são similares às encontradas em humanos. Por outro lado, diversos estudos têm relatado efeitos benéficos do estrógeno como um recurso importante para minimizar os efeitos deletérios do envelhecimento. Nesse contexto, com o objetivo precípuo de compreender as ações estrogênicas e suas influências no exercício aeróbio e anaeróbio foram realizados 2 trabalhos. O primeiro trabalho intitulado Perfil eletrocardiográfico de ratas envelhecidas treinadas e tratadas com estrógeno, cujo objetivo foi avaliar o perfil eletrocardiográfico de ratas tratadas com a associação de estrógeno e atividade física. Foram utilizadas ratas wistar com 1 ano e meio de idade, as quais foram submetidas a dois programas de exercício físico aeróbio (natação 3 sessões semanais/ 8 semanas) e anaeróbio (escalada em escada de 80 cm, 3 sessões semanais/ 8 semanas), incluindo um período de 2 semanas de adaptação para cada protocolo de treinamento. Foram avaliados a pressão arterial e o ECG considerando os intervalos QRS, QTc e PR. Os dados foram comparados através do teste T de student seguido do teste de Tukey, p< 0, 05. Os resultados desse estudo mostraram que o grupo tratado com estrógeno apresentou valores 21 % menores se comparado ao controle. Com relação ao treinamento foi observado que o treinamento aeróbio promoveu redução 25 % na FC, redução que atingiu 37, 2 % na presença do estrógeno. No treinamento anaeróbio foi observado redução de 28 % sendo acentuado para 40 % quando o estrógeno esteve presente. Dessa forma conclui-se que nas alterações cardíacas que acompanham o processo de envelhecimento, o tratamento com estrógeno isoladamente ou associado a prática de atividade física mostrou-se eficiente na manutenção bem como na melhora das condições metabólicas cardíacas. Seqüencialmente foi realizado o segundo trabalho intitulado Ações metabólicas do estrógeno em ratas submetidas a dois tipos de treinamento físico. A proposta deste estudo foi avaliar se ratas suplementadas com estrógeno apresentam melhores respostas frente à atividade física aeróbia e anaeróbia. Foram utilizadas ratas Wistar envelhecidas (1 ano e meio de idade) acondicionadas sob condições ideais de bioterismo e divididas em grupos experimentais denominados Controle e Tratadas com estrógeno (E, 160 &# 956;g/ 100 g), Treinado aeróbio e treinado anaeróbio tratados ou não com estrógeno. Foram coletadas amostras de sangue para avaliação bioquímica e amostras de diferentes músculos dos membros anteriores e posteriores para avaliação do conteúdo de glicogênio pelo método do fenol sulfúrico. Os resultados mostram que tanto o estrógeno quanto os diferentes treinamentos promoveram elevação nas reservas musculares de glicogênio, por outro lado, na associação do hormônio com o exercício físico, foi verificado um efeito aditivo que promoveu a melhora ainda mais expressiva nas condições energéticas. Associado a isto, foi verificado menores concentrações plasmáticas de ácidos graxos livres e gordura abdominal e ainda houve elevação na concentração de proteínas totais indicando ajustes na homeostasia metabólica, condição importante a ser preservada no processo de envelhecimento. The literature presents many alternatives {{of physical}} training and frequently reiterates {{the use of}} animal models for studies {{on the effect of}} training, as the results in animals are similar to those in humans. There is also the possibility of evaluating variables such as volume and intensity. In addition, many studies have reported beneficial effects of estrogen as an important resource to minimize the deleterious effects of aging. As a means of understanding estrogen action and its influence on aerobic and anaerobic exercise, four experiments were carried out in this context. The first study was called The behavior of glycogen reserves in female rats denervated muscle, with different doses of estrogen and aimed at evaluating the estrogen action on the glycogenic profiles of denervated skeletal muscle. Methods: The animals were divided in 6 experimental groups (n= 6) : control (C), denervated for 15 days (D), denervated and treated with estrogen 20 mg/weight/day (E 20), denervated and treated with estrogen 40 mg/weight/day (E 40), denervated and treated with estrogen 80 mg/weight/day (E 80) and denervated and treated with estrogen 160 mg/weight/day (E 160). The treatment was realized by 15 days and the choice substance was estradiol <b>cipionate.</b> The following analyses were carried out: glycogen reserves in soleus (S), white (WG) and red gastrocnemius (RG), body and soleus weights. The statistical analysis included the Kolmogorov-Smirnov test, ANOVA and post-hoc Tukey test (p< 0. 05). Results: The denervation induced a reduction in glycogen content in the S, WG and RG muscles. The groups treated with estrogen we observed a progressive elevation in glycogen reserves concomitant with the elevation of dose and reinstate the glycogen reserves, but the dose that shows a better action is 160 mg/weight/day were we observed the greatest quimiometabolic responses. Conclusions: These results suggest that estrogen may be an effective resource to minimize the metabolic compromising that follows the skeletal muscle atrophy induced by denervation. Subsequently, we conducted a study called Estrogen modulation of insulin secretion in isolated rat pancreatic islets, whose goal was to evaluate the sensitivity to glucose in pancreatic islets isolated from female rats treated with estradiol cypionate (160 mg/body weight/ 15 days) as well as its effect on concentration of protein kinase C and protein kinase A in isolated islets. For this purpose, islets were isolated from rats by the collagenase method to evaluate the secretory process in the presence of different concentrations of glucose. On the other hand, the concentration of the enzymes PKC and PKA was also performed by Western blotting. Statistical analysis was applied to normality test (Kolmogorov-Smirnov test) followed by Tukey test, p < 0. 05. The results showed that the group treated with estradiol cypionate had greater insulin secretion against the same concentration of glucose, and increase of concentration of PKA and PKC enzymes, compared to control. The results show insulinotropic properties of estrogen in synergy with glucose, which is the main insulin secretagogue, since the hormone did not alter the secretion at concentrations normoglycaemia. Possibly the focus of the secretagogue action of estrogen involves the activation of cytosolic enzyme pathways that determine the exudation of insulin. From these observations, we conducted the third study entitled "Electrocardiographic profile of aged rats trained and treated with estrogen, whose goal was to assess the eletrocardiographic profile of rats treated with the association of estrogen and physical activity. We used Wistar rats at 1 year of age, which were submitted to two programs of aerobic exercise (swimming 3 sessions weekly / 8 weeks) and anaerobic (climbing stairs of 80 cm, 3 sessions weekly / 8 weeks). We evaluated blood pressure and ECG intervals considering the QRS, QTc and PR. Data were compared by Student's t test followed by Tukey test, p < 0. 05. The findings of this study showed that the group treated with estrogen values were 21 % lower compared to the control group. With respect to training, we observed that aerobic training promoted 25 % reduction in FC, which reached 37. 2 % reduction in the presence of estrogen. In anaerobic training, we observed 28 % reduction, which was accentuated to 40 % when estrogen was present. Thus we conclude that treatment with estrogen alone or associated with physical activity was effective in maintaining and improving conditions in the metabolic and functional heart in the cardiac changes that accompany the aging process. Subsequently, we held the fourth paper entitled "Metabolic actions of estrogen in rats subjected to two types of physical training. The {{purpose of this study was}} to evaluate whether rats supplemented with estrogen show better responses to the aerobic and anaerobic physical activity. We used aged Wistar rats (13 months), placed under ideal conditions of bioterism and divided into experimental groups called Control and Treated with estrogen (E, 160 &# 956;g/ 100 g), Aerobically and Anaerobically trained, and Treated with estrogen or not. Blood samples were collected for biochemical evaluation and samples of different muscles of the anterior and posterior were collected for glycogen content assessment by the phenol sulfuric method. The outcomes show that both estrogen and the different workout programs promoted increase in muscle glycogen reserves. Besides, the association of hormone with exercise promoted an additional effect with further enhances in energy conditions. Additionally, we found lower plasma free fatty acids and abdominal fat, and there was also an increase in total protein concentration indicating adjustments in metabolic homeostasis, an important condition to be preserved in the aging process...|$|E

